Update in Cervical Cancer Screening

Host: Darryl S. Chutka, M.D. Guest: Stephen Kopecky, M.D. One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown signi ...  Show more

Host: Darryl S. Chutka, M.D. Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss ...  Show more

Recent research has shown that most, if not all, high grade serous ovarian cancers originate in the fallopian tubes. With no pronounced symptoms or tests to catch it early, ovarian cancer is usually detected in women with an average risk of cancer and in highly advanced stages. I ...  Show more

Here are 3 facts you should know: 1) Sex can cause cancer. 2) 8 out of 10 people will contract some form of HPV in their lifetime. 3) According to the Centers for Disease Control & Prevention (CDC), HPV is thought to be responsible for more than 90% of anal and cervical cancers, ...  Show more

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoin ...

In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ...  Show more